Coronavirus entry: how we arrived at SARS-CoV-2

Curr Opin Virol. 2021 Apr:47:113-120. doi: 10.1016/j.coviro.2021.02.006. Epub 2021 Mar 9.

Abstract

Because of the COVID-19 pandemic, the novel coronavirus SARS-CoV-2 has risen to shape scientific research during 2020, with its spike (S) protein being a predominant focus. The S protein is likely the most complicated of all viral glycoproteins and is a key factor in immunological responses and virus pathogenesis. It is also the driving force dictating virus entry mechanisms, which are highly 'plastic' for coronaviruses, allowing a plethora of options for different virus variants and strains in different cell types. Here we review coronavirus entry as a foundation for current work on SARS-CoV-2. We focus on the post-receptor binding events and cellular pathways that direct the membrane fusion events necessary for genome delivery, including S proteolytic priming and activation. We also address aspects of the entry process important for virus evolution and therapeutic development.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • COVID-19 / etiology*
  • COVID-19 / transmission
  • COVID-19 Drug Treatment
  • Humans
  • SARS-CoV-2 / physiology*
  • Signal Transduction / physiology
  • Spike Glycoprotein, Coronavirus / physiology
  • Virus Internalization* / drug effects

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2